Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors
Didanosine once daily: potential for expanded use
Correlation of virus load and soluble L-selectin, a marker of immune activation, in pediatric HIV-1 infection
The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in coinfected individuals
Cross-protection in NYVAC–HIV-1-immunized/HIV-2-challenged but not in NYVAC–HIV-2-immunized/SHIV-challenged rhesus macaques
Targeting cell-free HIV and virally-infected cells with anti-HLA-DR immunoliposomes containing amphotericin B
Ritonavir increases the level of active ADD-1/SREBP-1 protein during adipogenesis
Cell-mediated immune responses to autologous virus in HIV-1-seropositive individuals after treatment with an HIV-1 immunogen
Construction of infectious SIV/HIV-2 chimeras
Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection: the Scan Study
Competing drug–drug interactions among multidrug antiretroviral regimens used in the treatment of HIV-infected subjects: ACTG 884
A multicenter, randomized, double-blind, placebo-controlled trial of recombinant human interleukin-10 in HIV-infected subjects
A randomized, controlled 24-week study of intermittent subcutaneous interleukin-2 in HIV-1 infected patients in Thailand
HIV infection in Haiti: natural history and disease progression
Management of sexually transmitted diseases and HIV prevention in men at high risk: targeting clients and non-paying sexual partners of female sex workers in Benin
Risk factors for postnatal mother–child transmission of HIV-1
The cost-effectiveness of elective Cesarean delivery for HIV-infected women with detectable HIV RNA during pregnancy
Challenges in the conduct of vaginal microbicide effectiveness trials in the developing world
Epidemiology of Pneumocystis carinii pneumonia in an era of effective prophylaxis: the relative contribution of non-adherence and drug failure
Quality of life outcomes of combination zidovudine–didanosine–nevirapine and zidovudine–didanosine for antiretroviral-naive advanced HIV-infected patients
Risk behaviour change and HIV infection among injection drug users in Montreal
Complementary hypothesis concerning the community sexually transmitted disease mass treatment puzzle in Rakai, Uganda
Impact of highly active antiretroviral therapy on onset of Mycobacterium avium complex infection and cytomegalovirus disease in patients with AIDS
What a test for recent infection might reveal about HIV incidence in England and Wales
Cervicovaginal anti-HIV antibodies in HIV-seronegative female sex workers in Abidjan, Côte d'Ivoire
Fighting global AIDS: the value of cost-effectiveness analysis
Why does Pneumocystis carinii pneumonia still occur?
An outbreak of the circulating recombinant form AECM240 HIV-1 in the Finnish injection drug user population
Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy
Lack of significant viral load alterations of hepatitis B virus and hepatitis C virus during treatment with IL-2 and highly active antiretroviral therapy
Determination of HIV-1 circular DNA as a surrogate marker for residual virus replication in patients with undetectable virus loads
Once-daily indinavir plus ritonavir: preliminary results of the PIPO study
HIV-1 group N among HIV-1-seropositive individuals in Cameroon
Rapid quantification of SIV-specific CD8 T cell responses with recombinant vaccinia virus ELISPOT or cytokine flow cytometry
Increased levels of anti-CCR5 antibodies in sera from individuals immunized with allogeneic lymphocytes
Thresholds of CD4 cells for initiating trimethoprim-sulfamethoxazole prophylaxis in west Africa
Response to Eberly et al., Kaposi's sarcoma and central nervous system disease: a real association or an artifact of the control group?
Infection by zidovudine-resistant HIV-1 compromises the virological response to stavudine in a drug-naive patient